Literature DB >> 2863118

Sex and strain differences in hepatic debrisoquine 4-hydroxylase activity of the rat.

G C Kahn, M Rubenfield, D S Davies, S Murray, A R Boobis.   

Abstract

Debrisoquine 4-hydroxylase activity in microsomal fractions from liver of DA, Fischer, and Lewis rats has been determined. Activity in DA rats is up to 14-fold lower than in animals from the corresponding sex of the other strains. There is also a major sex difference in debrisoquine 4-hydroxylase activity of all three strains. Kinetic analysis revealed at least two components of activity, even in the liver of female DA rats. Thus, the decreased activity in these animals could not be attributed to the absence of a single isozyme of cytochrome P-450. Michaelis-Menten analysis revealed that both components of activity were impaired in these animals. Debrisoquine 4-hydroxylase activity was inducible by both 3-methylcholanthrene and phenobarbital in DA and Fischer rats. However, in the DA rat, activity was inducible only at higher substrate concentrations (greater than 50 microM). It is concluded that the DA rat differs from other strains in at least three different isozymes of cytochrome P-450 that can catalyze the 4-hydroxylation of debrisoquine. At least one of these is male-specific and at least one is inducible. The DA rat might provide a suitable model in which to predict which substrates might show impaired oxidation in the poor metabolizer phenotype, but studies on the molecular mechanism of the polymorphism in this strain would appear to have doubtful validity for the polymorphism in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863118

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

Review 1.  Sex Differences in Human and Animal Toxicology.

Authors:  Michael Gochfeld
Journal:  Toxicol Pathol       Date:  2016-11-28       Impact factor: 1.902

2.  Is the activation of aflatoxin B1 catalysed by the same form of cytochrome P-450 as that 4-hydroxylating debrisoquine in rat and/or man?

Authors:  S Plummer; A R Boobis; D S Davies
Journal:  Arch Toxicol       Date:  1986-02       Impact factor: 5.153

3.  Debrisoquine oxidation phenotype and susceptibility to lung cancer.

Authors:  C J Speirs; S Murray; D S Davies; A F Biola Mabadeje; A R Boobis
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

Review 4.  Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine.

Authors:  Deirdre P Campion; Fiona J Dowell
Journal:  Front Vet Sci       Date:  2019-02-11

5.  Strain differences in cytochrome P450 mRNA and protein expression, and enzymatic activity among Sprague Dawley, Wistar, Brown Norway and Dark Agouti rats.

Authors:  Yoshihiro Nishiyama; Shouta M M Nakayama; Kensuke P Watanabe; Yusuke K Kawai; Marumi Ohno; Yoshinori Ikenaka; Mayumi Ishizuka
Journal:  J Vet Med Sci       Date:  2016-01-22       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.